These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19181653)

  • 1. 84-year-old woman with hemodialysis-associated shortness of breath.
    Kapa S; Qian Q
    Mayo Clin Proc; 2009 Feb; 84(2):187-90; quiz 187-9. PubMed ID: 19181653
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparin-induced thrombocytopenia: diagnosis and management.
    Warkentin TE
    Circulation; 2004 Nov; 110(18):e454-8. PubMed ID: 15520327
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibodies to heparin-platelet factor 4 complex: pathogenesis, epidemiology, and management of heparin-induced thrombocytopenia in hemodialysis.
    Davenport A
    Am J Kidney Dis; 2009 Aug; 54(2):361-74. PubMed ID: 19481318
    [No Abstract]   [Full Text] [Related]  

  • 4. [Patient with heparin-induced thrombocytopenia type II and implanted left ventricular assist device].
    Lutz JT; Exner HJ; Schannewitzky A; Fehske W; Görlinger K
    Anaesthesist; 2008 Jan; 57(1):49-52. PubMed ID: 18209967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-induced thrombocytopenia: what clinicians need to know.
    Chong BH; Isaacs A
    Thromb Haemost; 2009 Feb; 101(2):279-83. PubMed ID: 19190810
    [No Abstract]   [Full Text] [Related]  

  • 6. Re-exposure to heparin in uremic patients requiring hemodialysis with heparin-induced thrombocytopenia.
    Wanaka K; Matsuo T; Matsuo M; Kaneko C; Miyashita K; Asada R; Matsushima H; Nakajima Y
    J Thromb Haemost; 2010 Mar; 8(3):616-8. PubMed ID: 20050999
    [No Abstract]   [Full Text] [Related]  

  • 7. Heparin-induced thrombocytopenia and cardiovascular patients: recognition and treatment.
    Baker KM; Flattery MP
    Prog Cardiovasc Nurs; 2006; 21(1):47-50. PubMed ID: 16522970
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment with argatroban in one haemodialysed patient with a heparin-induced thrombocytopenia and thrombotic complications.
    Alatri A; Foramitti M; Paoletti O; Zimmermann A; Testa S
    Intern Emerg Med; 2010 Aug; 5(4):359-60. PubMed ID: 20177820
    [No Abstract]   [Full Text] [Related]  

  • 9. Laboratory testing for heparin-induced thrombocytopenia.
    Warkentin TE
    J Thromb Thrombolysis; 2000 Nov; 10 Suppl 1():35-45. PubMed ID: 11155193
    [No Abstract]   [Full Text] [Related]  

  • 10. [Heparin-induced thrombocytopenia: the clinical picture and treatment].
    Matsuo T
    Rinsho Ketsueki; 2002 Jun; 43(6):464-7. PubMed ID: 12134702
    [No Abstract]   [Full Text] [Related]  

  • 11. Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II.
    Wellborn-Kim JJ; Mitchell GA; Terneus WF; Stowe CL; Malias MA; Sparkman GM; Hanson GW
    Am J Health Syst Pharm; 2010 Jul; 67(13):1075-9. PubMed ID: 20554593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-induced Thrombocytopenia with Anaphylactoid Reaction during Hemodialysis.
    Murakami Y; Tomoda A; Fujita S; Hayashi S; Hattori S; Sugiura T; Matsushima H
    Intern Med; 2024 Aug; 63(16):2321-2324. PubMed ID: 38072405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-induced thrombocytopenia and thrombosis.
    Arepally G; Cines DB
    Clin Rev Allergy Immunol; 1998; 16(3):237-47. PubMed ID: 9773251
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of anticoagulation in patients with subacute heparin-induced thrombocytopenia scheduled for heart transplantation.
    Selleng S; Haneya A; Hirt S; Selleng K; Schmid C; Greinacher A
    Blood; 2008 Nov; 112(10):4024-7. PubMed ID: 18791163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of acute systemic reaction and detection of IgG antibodies against PF4/heparin complexes in hemodialysis patients.
    Matsuo T; Wanaka K; Miyasita K; Prechel M; Walenga JM
    Thromb Res; 2012 Apr; 129(4):474-8. PubMed ID: 22088491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The paradox of heparin-induced thrombocytopenia: the initial management.
    Taylor LM; Smith KM
    Orthopedics; 2005 Jun; 28(6):559-62. PubMed ID: 16138467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-induced thrombocytopenia in hemodialysis patients.
    Yamamoto S; Koide M; Matsuo M; Suzuki S; Ohtaka M; Saika S; Matsuo T
    Am J Kidney Dis; 1996 Jul; 28(1):82-5. PubMed ID: 8712226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case report of successful transition from argatroban to warfarin using DOAC-stop in heparin induced thrombocytopenia (HIT).
    Makhija K; Chapman K; Prasad R
    Pathology; 2021 Oct; 53(6):800-802. PubMed ID: 33610318
    [No Abstract]   [Full Text] [Related]  

  • 19. Heparin-induced thrombocytopenia in patients administered heparin solely for hemodialysis.
    Murray PT; Hursting MJ
    Ren Fail; 2006; 28(7):537-9. PubMed ID: 17050234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodialysis-associated acute systemic reactions and heparin-induced thrombocytopenia.
    Warkentin TE
    Thromb Res; 2012 Apr; 129(4):405-6. PubMed ID: 22127211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.